Wednesday, February 8, 2023

Tag: aducanumab

Pharma Corruption, Dangers of Antidepressants, And More

2
Peter Simons covers news on mental health app Cerebral and pharma companies Biogen and Cassava; how social media influencers are the new pharma marketers; studies that found antidepressants don't improve quality of life and are harmful to the fetus when pregnant women take them; benzo withdrawal; and more!

FDA Approves Failed Alzheimer’s Drug

2
The FDA approved Biogen's failed drug aducanumab, overriding the 10-0 recommendation of its own advisory committee. Three panel members resigned in protest.

Ethical Issues Raised Over FDA Collaboration with Biogen on Failed Drug

7
The FDA collaborated with Biogen to conduct repeated re-analyses of aducanumab for Alzheimer's and FDA committee members are raising concerns.

Biogen Pushes FDA to Approve Failed Alzheimer’s Drug

2
A new analysis, published in Lancet Neurology, demonstrates how Biogen is spinning results from two failed trials for a new Alzheimer's drug.